Tapewire

Nasdaq · USD

NDRA

ENDRA Life Sciences Inc.

Export transactions ↓
Tapewire entity
8083
SEC CIK
0001681682
Parsed reports
173

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 12, 2017 Filed May 23, 2017 18:05 UTC Amendment GrantStock Options · Derivative 6,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001209191-17-034737 · doc4a.xml · derivative · entry 2

Tokman Alexander Y · CIK 0001334483 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2025-05-12

F2 · derivative.exercise_date: This amendment is being filed to correct the exercisable date of these Stock Options, which was inadvertantly reported as May 12, 2017. The correct exercisable date is December 31, 2017.

F1 · derivative.expiration_date: This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.

Read SEC document
May 12, 2017 Filed May 23, 2017 18:05 UTC Amendment GrantStock Options · Derivative 6,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001209191-17-034737 · doc4a.xml · derivative · entry 1

Tokman Alexander Y · CIK 0001334483 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2025-05-12

F1 · derivative.expiration_date: This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.

Read SEC document
May 12, 2017 Filed May 23, 2017 17:58 UTC GrantStock Options · Derivative 6,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001209191-17-034724 · doc4.xml · derivative · entry 2

Gambhir Sanjiv Sam · CIK 0001369005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2025-05-12

Read SEC document
May 12, 2017 Filed May 23, 2017 17:58 UTC GrantStock Options · Derivative 6,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001209191-17-034724 · doc4.xml · derivative · entry 1

Gambhir Sanjiv Sam · CIK 0001369005 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2025-05-12

Read SEC document
May 12, 2017 Filed May 23, 2017 22:07 UTC Amendment GrantStock Options · Derivative 6,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001209191-17-034739 · doc4a.xml · derivative · entry 2

Harsh Michael · CIK 0001706155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2025-05-12

F2 · derivative.exercise_date: This amendment is being filed to correct the exercisable date of these Stock Options, which was inadvertantly reported as May 12, 2017. The correct exercisable date is December 31, 2017.

F1 · derivative.expiration_date: This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.

Read SEC document
May 12, 2017 Filed May 23, 2017 22:07 UTC Amendment GrantStock Options · Derivative 6,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001209191-17-034739 · doc4a.xml · derivative · entry 1

Harsh Michael · CIK 0001706155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2025-05-12

F1 · derivative.expiration_date: This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.

Read SEC document
May 12, 2017 Filed May 23, 2017 22:02 UTC Amendment
Thornton Michael MilosChief Technology Officer
GrantStock Options · Derivative 313,338 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001209191-17-034733 · doc4a.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,338

Underlying: Common Stock · 313,338 shares

Expires 2025-05-12

F1 · derivative.exercise_date: These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.

F2 · derivative.expiration_date: This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.